Cogratulatios to Mark Hedrik ad our new CFO for a bag up job and for achieving the hoor of a possible delistig from nasdq.
Your skills have destroyed the market cap of the compay, the confidence of investors, ad has preveted the acceptace of what was thought of as a breakthrough technology.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
On October 30, 2014, Cytori Therapeutics, Inc., a Delaware corporation (the "Company"), received a letter (the "Notice") from the Listing Qualifications staff of The NASDAQ Stock Market LLC ("Nasdaq") indicating that, based upon the closing bid price of the Company's common stock for the last 30 consecutive business days, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5450(a)(1).
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a period of 180 calendar days, or until April 28, 2015, in which to regain compliance. In order to regain compliance with the minimum bid price requirement, the closing bid price of the Company's common stock must be at least $1 per share for a minimum of ten consecutive business days during this 180-day period. In the event that the Company does not regain compliance within this 180-day period, the Company may be eligible to seek an additional compliance period of 180 calendar days if it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Global Market, with the exception of the bid price requirement, and provides written notice to Nasdaq of its intent to cure the deficiency during this second compliance period, by effecting a reverse stock split, if necessary. However, if it appears to the Nasdaq Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice to the Company that its common stock will be subject to delisting.
The Notice does not result in the immediate delisting of the Company's common stock from the Nasdaq Global Market. The Company intends to monitor the closing bid price of the Company's common stock to allow a reasonable period for the price to rebound from its recent decline but will continue to consider its available options to regain compliance. There can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or maintain compliance with the other listing requirements.
I was not prepared for most of what has transpired with this POS company. The lies, mistakes, manipulations, the list goes on. We are at the mercy of this incompetent band of fools and I plan on doing whatever I legally can to be sure that this fiasco is investigated , exposed, and anyone be it management or board members found to be culpable for any thing the law deems illegal or improper held accountable.
This is being investigated and what steps will be taken or not will be determined shortly. If any investors feel that they want to be a part of any class action or other legal action which may be deemed appropriate let me know.